Nanopath Secures $10 Million to Commercialize Point-of-Care Diagnostics for Women
I-Corps alumni company Nanopath, which spun out of Dartmouth College, recently closed a $10 million Series A funding round. The funding will support development and commercialization of their biosensing platform that transforms how women’s pelvic and gynecologic infections are diagnosed.
read more